Bjorg-tilde S. Fevang

Bergen, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort.

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort.

Journal: European journal of internal medicine

Published: December 15, 2025

Patient-reported outcomes and disease activity in giant cell arteritis: a longitudinal registry-based study.

Patient-reported outcomes and disease activity in giant cell arteritis: a longitudinal registry-based study.

Journal: Rheumatology (Oxford, England)

Published: October 07, 2025

Correspondence on 'ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease' by Antoniou et al.

Correspondence on 'ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease' by Antoniou et al.

Journal: Annals of the rheumatic diseases

Published: September 14, 2025

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study.

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study.

Journal: European journal of internal medicine

Published: July 03, 2025

Data-driven identification of subgroups in early rheumatoid arthritis: mortality and cardiovascular disease in a cohort from western Norway.

Data-driven identification of subgroups in early rheumatoid arthritis: mortality and cardiovascular disease in a cohort from western Norway.

Journal: RMD open

Published: May 14, 2025

Treating rheumatoid arthritis in Zanzibar: a cost effectiveness study comparing conventional, biologic, and targeted-synthetic disease modifying anti-rheumatic drugs.

Treating rheumatoid arthritis in Zanzibar: a cost effectiveness study comparing conventional, biologic, and targeted-synthetic disease modifying anti-rheumatic drugs.

Journal: Frontiers in medicine

Published: April 26, 2025

Men with psoriatic arthritis, rheumatoid arthritis and axial spondylarthritis have more children and at an earlier age than matched controls: results from a nationwide cohort.

Men with psoriatic arthritis, rheumatoid arthritis and axial spondylarthritis have more children and at an earlier age than matched controls: results from a nationwide cohort.

Journal: RMD open

Published: April 07, 2025

Health-related quality of life among patients with rheumatoid arthritis in Zanzibar: a prospective cohort study.

Health-related quality of life among patients with rheumatoid arthritis in Zanzibar: a prospective cohort study.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: April 07, 2025

Treatment and risk of relapse in GCA in Western Norway 2013-2020: a retrospective cohort study.

Treatment and risk of relapse in GCA in Western Norway 2013-2020: a retrospective cohort study.

Journal: Rheumatology advances in practice

Published: March 28, 2025

Trends in stroke occurrence in rheumatoid arthritis: a retrospective cohort study from Western Norway, 1972 through 2020.

Trends in stroke occurrence in rheumatoid arthritis: a retrospective cohort study from Western Norway, 1972 through 2020.

Journal: Frontiers in medicine

Published: December 18, 2024

Male patients with inflammatory joint diseases are less likely than controls to be childless: results from a Norwegian population-based cohort study of 10 865 patients.

Male patients with inflammatory joint diseases are less likely than controls to be childless: results from a Norwegian population-based cohort study of 10 865 patients.

Journal: Annals of the rheumatic diseases

Published: September 28, 2023

Comparative Effectiveness and Persistence of SB4 and Reference Etanercept in Patients With Psoriatic Arthritis in Norway.

Comparative Effectiveness and Persistence of SB4 and Reference Etanercept in Patients With Psoriatic Arthritis in Norway.

Journal: Arthritis care & research

Published: September 28, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026